Individualized and inverse optimized needle configuration for combined intracavitary-interstitial brachytherapy in locally advanced cervical cancer

被引:11
|
作者
Zhang, Daguang [1 ]
Yang, Zhiyong [1 ]
Jiang, Shan [1 ]
Zhou, Lin [1 ]
Zhou, Zeyang [1 ]
Wang, Wei [2 ]
机构
[1] Tianjin Univ, Sch Mech Engn, 135 Yaguan Rd,Haihe Educ Pk, Tianjin 300350, Peoples R China
[2] Tianjin Med Univ Canc Inst & Hosp, Dept Radiat Oncol, Tianjin, Peoples R China
关键词
Applicators; cervical cancer; combined intracavitary-interstitial brachytherapy; individualized design; inverse treatment planning; SOCIETY CONSENSUS GUIDELINES; AMERICAN BRACHYTHERAPY; CLINICAL FEASIBILITY; ADVANCED-CARCINOMA; VIENNA APPLICATOR; ALGORITHM; IMPROVES;
D O I
10.4103/jcrt.JCRT_292_19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: The aim of this study is to address the limitation of combined intracavitary-interstitial (IC/IS) brachytherapy (BT) in locally advanced cervical cancer using standardized applicators and to determine the optimal dose distribution in patients with challenging tumors, innovative methods of customizing and optimizing the IS needle configuration for combined IC/IS BT are proposed and investigated. Materials and Methods: A software module that could customize the IS needle configuration and subsequently generate the digital model of guiding template for three-dimensional printing was developed and integrated into our in-house treatment planning system for BT. The inverse optimization method based on the technique of mixed-integer linear programming was introduced to determine the needle tracks out of a candidate pool and dwell times at corresponding locations to best meet dose objectives. A treatment planning study was conducted to evaluate the feasibility and performance of the proposed methods. Results: The workflow for combined IC/IS BT with customized and inverse optimized IS needle configuration was presented. Dosimetric results of the treatment planning study showed that sufficient target coverage could be obtained with the customized IS needle configuration for challenging cases. The proposed dose-based optimization method for IS needle configuration was feasible and effective. Improved target coverage and organ-at-risk sparing were achieved using the inverse planning method. Conclusions: Using the proposed methods of customizing and optimizing the IS needle configuration, the limitation in the standardized design of combined IC/IS applicators can be addressed, and sufficient target coverage is obtained in cervical cancer patients with unfavorable tumor topography and/or extra lateral expansion.
引用
收藏
页码:1589 / 1596
页数:8
相关论文
共 50 条
  • [1] Combined intracavitary and interstitial brachytherapy in locally advanced cervical cancer.
    Piccolo, F.
    Pappalardi, B.
    Carrara, M.
    Tenconi, C.
    Giandini, T.
    Delle Curti, C.
    Fallai, C.
    Cerrotta, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S599 - S599
  • [2] Inverse planning for combination of intracavitary and interstitial brachytherapy for locally advanced cervical cancer
    Yoshio, Kotaro
    Murakami, Naoya
    Morota, Madoka
    Harada, Ken
    Kitaguchi, Mayuka
    Yamagishi, Kentaro
    Sekii, Shuhei
    Takahashi, Kana
    Inaba, Koji
    Mayahara, Hiroshi
    Ito, Yoshinori
    Sumi, Minako
    Kanazawa, Susumu
    Itami, Jun
    JOURNAL OF RADIATION RESEARCH, 2013, 54 (06) : 1146 - 1152
  • [3] Clinical outcome of intracavitary and interstitial brachytherapy in locally advanced cervical cancer
    Chitmanee, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S154 - S154
  • [4] Image-guided intracavitary and interstitial brachytherapy in locally advanced cervical cancer
    Chitmanee, P.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1929 - S1930
  • [5] Impact of combined interstitial and intracavitary brachytherapy in locally advanced cervical cancer: A survival and toxicity profile assessment
    Pareek, V.
    Chandra, M.
    Bhalavat, R.
    ANNALS OF ONCOLOGY, 2019, 30 : 428 - 428
  • [6] CLINICAL USE OF THE UTRECHT APPLICATOR FOR COMBINED INTRACAVITARY/INTERSTITIAL BRACHYTHERAPY TREATMENT IN LOCALLY ADVANCED CERVICAL CANCER
    Nomden, Christel N.
    de Leeuw, Astrid A. C.
    Moerland, Marinus A.
    Roesink, Judith M.
    Tersteeg, Robbert J. H. A.
    Jurgenliemk-Schulz, Ina Maria
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (04): : 1424 - 1430
  • [7] Clinical outcome of combined intracavitary/interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer
    Rogowski, Paul
    Rottler, Maya
    Walter, Franziska
    Saicic, Stefan
    Niyazi, Maximilian
    Well, Justus
    Nierer, Lukas
    Trillsch, Fabian
    Burges, Alexander
    Mahner, Sven
    Belka, Claus
    Corradini, Stefanie
    GYNECOLOGIC ONCOLOGY, 2022, 166 (03) : 576 - 581
  • [8] Impact of combined interstitial and intracavitary brachytherapy in locally advanced cervical cancer: A survival and toxicity profile assessment
    Pareek, V.
    Bhalavat, R.
    Chandra, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] Computed Tomography-Guided Optimization of Needle Insertion for Combined Intracavitary/ Interstitial Brachytherapy With Utrecht Applicator in Locally Advanced Cervical Cancer
    Tambas, Makbule
    Tavli, Busra
    Bilici, Nazli
    Dizman, Aysen
    Sertel, Huseyin
    Fayda, Merdan
    PRACTICAL RADIATION ONCOLOGY, 2021, 11 (04) : 272 - 281
  • [10] Parametrial boosting in locally advanced cervical cancer: Combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy
    Mohamed, Sandy
    Kallehauge, Jesper
    Fokdal, Lars
    Lindegaard, Jacob Christian
    Tanderup, Karl
    BRACHYTHERAPY, 2015, 14 (01) : 23 - 28